UT MPJE study materials
UT MPJE study resources

Late-Night Oxycodone, Cash Pay, and Four Red Flags

UT MPJE · Put your knowledge to work in context.

All case studies

Late-Night Oxycodone, Cash Pay, and Four Red Flags

A 34-year-old man presents an electronically transmitted prescription at a community pharmacy in West Valley City at 8:45 p.m.: oxycodone 30 mg, quantity 120, no refills, from a physician whose office is 70 miles away in another state. He is paying cash, has never filled at this pharmacy, and gives no diagnosis. A PDMP query shows three opioid prescriptions filled in the past 11 days at three different pharmacies from two prescribers, plus an active buprenorphine prescription and no controlled substance history before last month. The prescriber's office is closed and the voicemail box is full. The patient says he is only in town briefly and needs the medication tonight, and becomes loud when the pharmacist says verification may take time.

1. May the pharmacist decline to fill this prescription? What must the pharmacist do and document before making that decision?

Read the worked answer

Yes. A DEA registration authorizes a pharmacy to dispense controlled substances; it does not compel the fill of every prescription presented. Federal law places corresponding responsibility on the dispensing pharmacist (21 CFR 1306.04(a)): the pharmacist must resolve red flags or decline. Filling with unresolved red flags is itself a violation.

Red flags present: cash payment for a high-quantity Schedule II opioid, new patient, long distance from prescriber, late evening when the prescriber cannot be reached, multiple prescribers and multiple pharmacies in a short window, and concurrent buprenorphine (a partial agonist) with a full agonist opioid.

Steps before deciding:

  • Query the PDMP and review the full record, including the buprenorphine history and whether the patient appears to be in treatment.
  • Attempt direct prescriber contact (phone, fax, after-hours line); document each attempt with time and outcome.
  • Ask the patient specific, non-accusatory questions (injury, surgery, prior therapy, who manages the buprenorphine, why traveling).
  • Consider whether the buprenorphine prescriber can be reached, or whether the buprenorphine reflects treated opioid use disorder that makes the regimen clinically questionable.

Documentation: PDMP review, questions asked, calls attempted with times, patient statements, and the rationale for the final decision. If the pharmacist declines, tell the patient clearly that the prescription was not filled, explain that the prescriber must cancel or redirect it (an e-prescription cannot be physically handed back), and document the refusal. Do not keep or destroy the prescription without recording what happened to it.

2. What does Utah law and the PDMP require of this dispensing pharmacist specifically, and how should PDMP information be used and protected?

Read the worked answer

Reporting: Utah requires dispensers to report each controlled substance dispensed to the state controlled substance database on the schedule set by statute and board rule (confirm the current submission deadline in Utah Code Title 58, Chapter 37f and the companion administrative rule). Reporting does not depend on whether the pharmacist thought the fill was appropriate.

Checking: Utah's mandatory database-check provisions are directed primarily at prescribers in defined circumstances; for the pharmacist, the obligation to look flows from corresponding responsibility and the Board's expectation of a good-faith inquiry when red flags appear. A pharmacist who sees duplicate therapy and does not look further and does not resolve it has a weak position if the fill is later reviewed.

Use and protection of the data: PDMP data is confidential, use-restricted information. It may be used for patient care and legitimate professional purposes, not for curiosity, employment screening, or discussion with third parties. Do not read the screen aloud to a patient or family member; note that the database was queried rather than pasting identifying details of other prescriptions into narrative fields unnecessarily. Improper access or disclosure is itself a compliance problem, separate from the dispensing decision.

3. If the pharmacist resolves enough concerns to dispense something tonight but the pharmacy has only 40 tablets, what are the partial-fill rules for this Schedule II prescription?

Read the worked answer

Two different partial-fill rules apply, and they are not interchangeable:

  1. Patient- or prescriber-requested partial fill. Federal law permits a partial fill of a Schedule II prescription at the request of the patient or the prescriber, with the remainder supplied within 30 days of the date the prescription was written. The pharmacy must record the date of the partial fill, the quantity dispensed, the quantity remaining, and the identity of the dispensing pharmacist.
  2. Insufficient supply. If the pharmacy cannot supply the full quantity, it may dispense a partial quantity, but the remainder must be supplied within 72 hours; if it is not, the pharmacist must notify the prescriber, and no further quantity may be dispensed on that prescription.

Practical points: a partial fill does not launder the red flags - the pharmacist still must document the same clinical reasoning for the 40 tablets. Because option 2 gives only 72 hours and the prescriber is unreachable tonight, the pharmacist should generally ask the patient which option he is choosing and record it, rather than defaulting. Utah law on partial fills should be checked for any state-specific notation or reporting requirement; the stricter of federal and state rules controls.